Biotech Hedge Funds: A Match Made in Heaven
Mergers and Inquisitions
MARCH 5, 2025
In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e.,
64 
Let's personalize your content